- Home
- BDTX vs MSI Comparison
BDTX vs MSI Comparison
Compare BDTX & MSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- MSI
- Stock Information
- Founded
- BDTX 2014
- MSI 1928
- Country
- BDTX United States
- MSI United States
- Employees
- BDTX N/A
- MSI N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- MSI Radio And Television Broadcasting And Communications Equipment
- Sector
- BDTX Health Care
- MSI Technology
- Exchange
- BDTX Nasdaq
- MSI Nasdaq
- Market Cap
- BDTX 132.5M
- MSI 67.6B
- IPO Year
- BDTX 2020
- MSI N/A
- Fundamental
- Price
- BDTX $2.60
- MSI $422.13
- Analyst Decision
- BDTX Strong Buy
- MSI Strong Buy
- Analyst Count
- BDTX 6
- MSI 9
- Target Price
- BDTX $14.83
- MSI $505.11
- AVG Volume (30 Days)
- BDTX 1.3M
- MSI 925.7K
- Earning Date
- BDTX 08-05-2025
- MSI 07-31-2025
- Dividend Yield
- BDTX N/A
- MSI 1.03%
- EPS Growth
- BDTX N/A
- MSI 45.79
- EPS
- BDTX 0.09
- MSI 11.91
- Revenue
- BDTX $70,000,000.00
- MSI $10,956,000,000.00
- Revenue This Year
- BDTX N/A
- MSI $6.61
- Revenue Next Year
- BDTX N/A
- MSI $5.69
- P/E Ratio
- BDTX $28.15
- MSI $35.44
- Revenue Growth
- BDTX N/A
- MSI 7.45
- 52 Week Low
- BDTX $1.20
- MSI $384.51
- 52 Week High
- BDTX $6.75
- MSI $507.82
- Technical
- Relative Strength Index (RSI)
- BDTX 61.72
- MSI 56.46
- Support Level
- BDTX $2.34
- MSI $411.60
- Resistance Level
- BDTX $2.71
- MSI $427.40
- Average True Range (ATR)
- BDTX 0.18
- MSI 6.43
- MACD
- BDTX -0.01
- MSI 1.78
- Stochastic Oscillator
- BDTX 79.65
- MSI 77.56
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About MSI Motorola Solutions Inc.
Motorola Solutions is a leading provider of communications and analytics, primarily serving public safety departments as well as schools, hospitals, and businesses. The bulk of the firm's revenue comes from sales of land mobile radios and radio network infrastructure, but the firm also sells surveillance equipment and dispatch software. Most of Motorola's revenue comes from government agencies, while roughly 25% comes from schools and private businesses. Motorola has customers in over 100 countries and in every state in the United States.